Variables | Mandla | Balaghat (N = 230) | Dindori (N = 184) | |
---|---|---|---|---|
Baseline (N = 220) | End line§ (N = 261) | |||
Treatment of malaria cases using anti-malarials | ||||
Choloroquine for treatment of P. vivax | 187 (85.00) | 221 (84.67) | 190 (82.61) | 137 (74.46)** |
ACT blister pack for treatment of P. falciparum | 98 (44.55) | 127 (48.66) | 69 (30.00)*** | 81 (44.02) |
Refer | 22 (10.00)* | 12 (4.60) | 2 (0.87)** | 0 (0.00)** |
Do not treat/refer | 16 (7.27)** | 3 (1.15) | 3 (1.30)** | 9 (4.89)* |
Provide primaquine | ||||
For P. vivax cases | 134 (60.91)** | 191 (73.18) | 122 (53.04)*** | 74 (40.22)*** |
For 14 days | 88 (40.00)*** | 165 (63.22) | 75 (32.61)*** | 48 (26.09)*** |
For P. falciparum cases | 109 (49.55)** | 161 (61.69) | 112 (48.70)** | 64 (34.78)*** |
For state one day | 73 (33.18)*** | 133 (50.96) | 77 (33.48)*** | 45 (24.46)*** |
Adhere to malaria treatment national policy | 189 (85.91)* | 240 (91.95) | 194 (84.35)** | 146 (79.35)*** |
Proportion of correctly matched the ACT colored blister pack according to the age group (Correctly matched/Total blister pack) | ||||
0 (0/5) | 145 (65.91)*** | 7 (2.68) | 182 (79.13)*** | 170 (92.39)*** |
20 (1/5) | 20 (9.09) | 21 (8.05) | 13 (5.65) | 5 (2.72)* |
40 (2/5) | 27 (12.27) | 36(13.79) | 34 (14.78) | 7 (3.80)** |
60 (3/5) | 12 (5.45) | 17 (6.51) | 0*** | 1 (0.54)** |
80 (4/5) | 2 (0.91)*** | 32 (12.26) | 0*** | 0*** |
100 (5/5) | 14 (6.36)*** | 148 (56.70) | 1 (0.43)*** | 1 (0.54)*** |
Proportion of correctly interpreted RDT result (Correctly interpreted/Total test) | ||||
0 (0/6) | 15 (6.82)** | 3 (1.15) | 4 (1.74) | 9 (4.89)* |
16.67 (1/6) | 19 (8.64)** | 7 (2.68) | 15 (6.52)* | 22 (11.96)*** |
33.33 (2/6) | 10 (4.55)* | 4 (1.53) | 8 (3.48) | 5 (2.72) |
50.00 (3/6) | 33 (15.00)** | 15 (5.75) | 29 (12.61)** | 12 (6.52) |
66.67 (4/6) | 49 (22.27) | 46 (17.62) | 61 (26.52)* | 41 (22.28) |
83.33 (5/6) | 31 (14.09) | 26 (9.96) | 34 (14.78) | 63 (34.24)*** |
100.00 (6/6) | 63 (28.64)*** | 160 (61.30) | 79 (34.35)*** | 32 (17.39)*** |